Rubin HR, Gandek B, Rogers WH, et al. 1993. Patients' ratings of outpatient visits in different practice settings. Results from the medical outcomes study. Journal of the American Medical Association 270:835-840.

Samet JM, Hunt WC, Farrow DC. 1994. Determinants of receiving breast-conserving surgery. The Surveillance, Epidemiology, and End Results Program, 1983-1986. Cancer 73:2344-2351.

Sarrazin D, Le M, Rouesse J, et al. 1984. Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less: The experience of the Institut Gustave-Roussy. Cancer 53:1209-1213.

Schag CA, Heinrich RL. 1990. Development of a comprehensive quality of life measurement tool: CARES. Oncology 4:135-138.

Schatzkin A, Freedman LS, Dorgan J, et al. 1996. Surrogate end points in cancer research: A critique. Cancer Epidemiology, Biomarkers, and Prevention 5:947-953.

Schipper H, Clinch J, McMurray A, et al. 1984. Measuring the quality of life of cancer patients: The Functional Living Index—Cancer: Development and validation. Journal of Clinical Oncology 2:472-483.

Schleifer S, Bhardwaj S, Lebovits A, et al. 1991. Predictors of physician nonadherence to chemotherapy regimens. Cancer 67: 945-951.

Schuster MA, McGlynn EA, Brook RH. 1998. How good is the quality of health care in the United States? Milbank Quarterly 76(4):509, 517-563.

Segal M. 1994. Mammography facilities must meet quality standards. FDA Consumer 8-12.

Shapiro S, Venet W, Strax P, et al. 1988. Periodic Screening for Breast CancerThe Health Insurance Plan Project and Its Sequelae, 1963-1986. Baltimore, MD: Johns Hopkins University Press.

Simon MS, Stano M, Severson RK, et al. 1996. Clinical surveillance for early stage breast cancer: An analysis of claims data. Breast Cancer Research and Treatment 40:119-128.

Stolier AJ. 1997. Stereotactic breast biopsy: A surgical series. Journal of the American College of Surgeons 185:224-228.

Surveillance, Epidemiology, and End Results Program. 1998.

Swan J, Wingo P, Clive R, et al. 1998. Cancer surveillance in the U.S.: Can we have a national system? Cancer 83:1282-1291.

Tabar L, Fagerberg G, Chen H-H, et al. 1995. Efficacy of breast cancer screening by age. New results from the Swedish two-county trial. Cancer 75:2507-2517.

Talamonti MS, Morrow M. 1996. The abnormal mammogram. Pp. 114-122 in Harris JR, Morrow M, Lippman ME, Hellman S, eds. Diseases of the Breast. New York: Lippincott-Raven Publishers.

Talcott JA. 1996. Quality of life in early prostate cancer: Do we know enough to treat? Hematology/Oncology Clinics of North America 10(3):691-701.

U.S. Department of Health and Human Services. 1996. Guide to Clinical Preventive Services. Report of the U.S. Preventive Services Task Force. Second Edition. Washington, D.C.

U.S. General Accounting Office. 1988. Cancer Treatments 1975-85: The Use of Breakthrough Treatments for Seven Types of Cancer. PIC ID No. 3068.1:1-21. Washington, D.C.

U.S. General Accounting Office. 1998a. Mammography Quality Standards Act: X-ray quality improved, access unaffected, but impact on health outcomes unknown. GAO/T-HEHS-98-164.

U.S. General Accounting Office. 1998b. Mammography services: Impact of federal legislation on quality, access, and health outcomes. GAO/HEHS-98-11.

Veronesi U, Saccozzi R, Del Vecchio M, et al. 1981. Comparing radical mastectomy with quandrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. New England Journal of Medicine 305:6-11.

von Eschenbach A, Ho R, Murphy GP, Cunningham M, Lins N. 1997. American Cancer Society guideline for the early detection of prostate cancer: Update 1997. CA: Cancer Journal for Clinicians 47:261-264.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement